Results 291 to 300 of about 283,343 (354)
Some of the next articles are maybe not open access.

Methotrexate

Home Healthcare Now, 2015
The purpose of this article is to educate healthcare professionals about the many uses of the drug Methotrexate. Information regarding dosing, action, contraindications, adverse effects, drug interactions, as well as tips for patient education are included.
openaire   +4 more sources

Methotrexate Nodulosis

The Journal of Dermatology, 1999
AbstractMethotrexate (MTX) nodulosis in patients with rheumatoid arthritis treated with MTX has become a well recognized phenomenon. It has not been described in patients receiving MTX for treatment of other diseases, e.g., dermatological or malignant diseases. Recently, MTX nodulosis was described in a patient with psoriasis and arthritis.
K A, Jang   +5 more
openaire   +2 more sources

Methotrexate osteopathy

Skeletal Radiology, 1984
Methotrexate osteopathy is an uncommon complication of long-term oral maintenance therapy for childhood neoplasms, most commonly acute lymphocytic leukemia. It is characterized by severe lower extremity pain and by osteoporosis particularly involving the lower extremities and thick dense provisional zones of calcification and growth arrest lines ...
A M, Schwartz, J C, Leonidas
openaire   +2 more sources

Methotrexate bioavailability.

Clinical and experimental rheumatology, 2010
The clinical relevance of the concept of bioavailability rests on two main principles. First, that measurement of the active component at the site of action is generally not possible and, secondly, that a relationship exists between on the one hand efficacy and/or safety and on the other hand concentration of the active compound or its active ...
van Roon, E.N., van de Laar, Mart A F J
openaire   +3 more sources

Pharmacokinetics of Methotrexate and 7-Hydroxy-Methotrexate After Methotrexate Infusions

Cancer Drug Delivery, 1987
Methotrexate was administered by IV infusion, 2g (1.19 +/- 0.05 g/m2) over 24 hours, to a homogeneous group of patients undergoing treatment for breast cancer. Three courses were given at three week intervals. Methotrexate and 7-hydroxy-methotrexate plasma and urine pharmacokinetics were investigated. The average terminal half-lives of methotrexate and
P, Bore   +4 more
openaire   +2 more sources

Methotrexate polyglutamates

Expert Review of Clinical Pharmacology
Methotrexate polyglutamates (MTXPGs) are intracellular metabolites of methotrexate (MTX) that play a critical role in the drug's activity, influencing both its efficacy and toxicity. As the exact implications of MTXPGs in these processes remain a subject of debate, a comprehensive review of MTXPGs could provide valuable insights for clinicians and ...
Zhilin, Yang   +4 more
openaire   +2 more sources

METHOTREXATE HEPATOTOXICITY

Rheumatic Disease Clinics of North America, 1997
Hepatoxicity is a major adverse reaction that can occur during methotrexate treatment of the rheumatic diseases. The pathologic lesions are nonspecific and the pathogenesis is poorly understood. Early studies in psoriasis clearly established a relationship between hepatic injury and several risk factors, particularly alcohol use.
openaire   +2 more sources

Home - About - Disclaimer - Privacy